Steg, Leonard C.
Shireby, Gemma L.
Imm, Jennifer
Davies, Jonathan P.
Franklin, Alice
Flynn, Robert
Namboori, Seema C.
Bhinge, Akshay
Jeffries, Aaron R.
Burrage, Joe
Neilson, Grant W. A.
Walker, Emma M.
Perfect, Leo W.
Price, Jack
McAlonan, Grainne
Srivastava, Deepak P.
Bray, Nicholas J.
Cope, Emma L.
Jones, Kimberley M.
Allen, Nicholas D.
Pishva, Ehsan
Dempster, Emma L.
Lunnon, Katie
Mill, Jonathan
Hannon, Eilis https://orcid.org/0000-0001-6840-072X
Funding for this research was provided by:
Simons Foundation Autism Research Initiative (573312)
Medical Research Council (G0700089, K013807)
Medical Research Council UK (MR/L010674/2, N013255/1)
Wellcome Trust (GR082557)
EU-AIMS (115300)
Innovative Medicines Initiative (115439-2)
Article History
Received: 14 October 2020
Accepted: 14 June 2021
First Online: 26 June 2021
Declarations
:
: Ethical approval for the collection of human fetal brain tissue acquired from the Human Developmental Biology Resource was granted by the Royal Free Hospital research ethics committee under reference 08/H0712/34 and Human Tissue Authority material storage license 12220. Ethical approval for collection of human fetal brain tissue for the Medical Research Council Brain Bank was granted under reference 08/MRE09/38. Ethical approval for the work with methylomic data of human brain tissue from the BDR cohort was granted by the University of Exeter, College of Medicine and Health Research Ethics Committee under reference Mar20/D/009∆5. Ethical approval for the Price cellular samples is as follows: participants were recruited and methods carried out in accordance to the ‘Patient iPSCs for Neurodevelopmental Disorders (PiNDs) study’ (REC No 13/LO/1218). Informed consent was obtained from all subjects for participation in the PiNDs study. Ethical approval for the PiNDs study was provided by the NHS Research Ethics Committee at the South London and Maudsley (SLaM) NHS R&D Office.
: Not applicable.
: The authors declare that they have no competing interests.